Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco

Jihane Belayachi, Majdouline Obtel, Rachid Razine, Redouane Abouqal
doi: https://doi.org/10.1101/2022.01.25.22269822

Article Information

doi 
https://doi.org/10.1101/2022.01.25.22269822
History 
  • January 27, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Jihane Belayachi1,2,
  2. Majdouline Obtel2,3,
  3. Rachid Razine2,3 and
  4. Redouane Abouqal1,2,*
  1. 1Acute Medical Unit, Ibn Sina University Hospital, 10000, Rabat, Morocco
  2. 2Laboratory of Biostatistics, Clinical, and Epidemiological Research, Department of Public Health, Faculty of Medicine and Pharmacy - Mohamed V University in Rabat, Morocco
  3. 3Laboratory of Community Health (Public Health, Preventive Medicine and Hygiene) Department of Public Health, Faculty of Medicine and Pharmacy - Mohamed V University in Rabat, Morocco
  1. ↵*Corresponding author:
    Pr Redouane Abouqal at Acute Medical Unit, Ibn Sina University Hospital, 10000, Rabat, Morocco, E-mail:
    r.abouqal{at}um5r.ac.ma, Tel:
    +212661224739; Fax: +212537672558
Back to top
Posted January 27, 2022.
Download PDF
Data/Code
Email
Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco
Jihane Belayachi, Majdouline Obtel, Rachid Razine, Redouane Abouqal
medRxiv 2022.01.25.22269822; doi: https://doi.org/10.1101/2022.01.25.22269822
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area